René Russo
Overview
René Russo received an average of $3M in total compensation, including $527K in salary, at Xilio Therapeutics from 2020 to 2023. René Russo also received an average of $978K at X4 Pharmaceuticals between 2016 and 2017.
- 2023
- 2022
- 2021
- 2020
- 2017
- 2016
Xilio TherapeuticsPresident and Chief Executive Officer
Xilio TherapeuticsChief Executive Officer
Xilio TherapeuticsPresident and Chief Executive Officer
Xilio TherapeuticsPresident and Chief Executive Officer
X4 PharmaceuticalsPresident and Chief Executive Officer
X4 PharmaceuticalsPresident and Chief Executive Officer
Source: SEC filings on April 25, 2024, April 25, 2023, April 26, 2022, and April 23, 2018.
Related executives
We found 14 more executives who work or worked at Xilio Therapeutics and X4 Pharmaceuticals.
Christopher Frankenfield
Xilio Therapeutics
Chief Operating Officer
Martin Huber
Xilio Therapeutics
Former President and Head of R&D
Katarina Luptakova
Xilio Therapeutics
Chief Medical Officer
Paula Ragan
X4 Pharmaceuticals
Chief Executive Officer
Adam Mostafa
X4 Pharmaceuticals
Chief Financial Officer
Mary DiBiase
X4 Pharmaceuticals
Chief Operating Officer
Salvatore Giovine
Xilio Therapeutics
Chief Financial Officer
Derek Meisner
X4 Pharmaceuticals